Youssef Farag, M.B.,B.Ch.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Renal Insufficiency, Chronic | 17 | 2024 | 2254 | 2.170 |
Why?
|
Anemia | 11 | 2024 | 1504 | 1.670 |
Why?
|
Hematinics | 5 | 2022 | 282 | 0.950 |
Why?
|
Hemoglobins | 7 | 2022 | 1525 | 0.920 |
Why?
|
Picolinic Acids | 5 | 2022 | 50 | 0.790 |
Why?
|
Renal Dialysis | 7 | 2024 | 1796 | 0.780 |
Why?
|
Diabetic Nephropathies | 5 | 2024 | 973 | 0.700 |
Why?
|
Erythropoietin | 3 | 2022 | 719 | 0.700 |
Why?
|
Ferric Compounds | 1 | 2021 | 378 | 0.660 |
Why?
|
Kidney Failure, Chronic | 5 | 2024 | 2478 | 0.640 |
Why?
|
Glycine | 5 | 2022 | 659 | 0.630 |
Why?
|
Kidney Diseases | 6 | 2019 | 2092 | 0.590 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2021 | 369 | 0.560 |
Why?
|
Hypertension, Renal | 1 | 2014 | 135 | 0.450 |
Why?
|
Erectile Dysfunction | 1 | 2016 | 444 | 0.420 |
Why?
|
Vitamin D Deficiency | 3 | 2019 | 1388 | 0.410 |
Why?
|
Occupational Exposure | 1 | 2020 | 1814 | 0.350 |
Why?
|
Mass Screening | 3 | 2014 | 5426 | 0.320 |
Why?
|
Glomerular Filtration Rate | 7 | 2023 | 2182 | 0.310 |
Why?
|
Platelet Activation | 1 | 2012 | 646 | 0.310 |
Why?
|
Ethylene Glycol | 1 | 2008 | 31 | 0.310 |
Why?
|
Calcium Oxalate | 1 | 2008 | 75 | 0.290 |
Why?
|
Periodontitis | 2 | 2023 | 568 | 0.290 |
Why?
|
Nutrition Surveys | 4 | 2023 | 1723 | 0.270 |
Why?
|
Kidney | 5 | 2019 | 7033 | 0.250 |
Why?
|
Nephrology | 2 | 2019 | 263 | 0.230 |
Why?
|
Cost of Illness | 1 | 2014 | 1936 | 0.230 |
Why?
|
Renal Insufficiency | 2 | 2023 | 808 | 0.220 |
Why?
|
Disease Outbreaks | 1 | 2012 | 1747 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3093 | 0.210 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2023 | 109 | 0.210 |
Why?
|
Prevalence | 13 | 2023 | 15721 | 0.200 |
Why?
|
Egypt | 1 | 2022 | 98 | 0.200 |
Why?
|
India | 3 | 2020 | 2287 | 0.200 |
Why?
|
Glomerulosclerosis, Focal Segmental | 3 | 2011 | 335 | 0.190 |
Why?
|
Middle East | 2 | 2012 | 231 | 0.190 |
Why?
|
Hyperkalemia | 1 | 2023 | 233 | 0.190 |
Why?
|
Blood Platelets | 1 | 2012 | 2477 | 0.190 |
Why?
|
Tooth Loss | 1 | 2022 | 200 | 0.180 |
Why?
|
Epoetin Alfa | 1 | 2020 | 78 | 0.180 |
Why?
|
Saudi Arabia | 6 | 2016 | 210 | 0.170 |
Why?
|
Blood Component Transfusion | 1 | 2020 | 142 | 0.170 |
Why?
|
Tobacco, Smokeless | 1 | 2020 | 133 | 0.170 |
Why?
|
Ferritins | 3 | 2024 | 596 | 0.160 |
Why?
|
Suicide, Attempted | 1 | 2008 | 1402 | 0.160 |
Why?
|
Kidney Glomerulus | 3 | 2011 | 567 | 0.160 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5842 | 0.160 |
Why?
|
Humans | 48 | 2024 | 761208 | 0.150 |
Why?
|
Immunization, Passive | 1 | 2020 | 617 | 0.150 |
Why?
|
Phosphates | 1 | 2021 | 763 | 0.150 |
Why?
|
Acute Kidney Injury | 2 | 2023 | 1923 | 0.140 |
Why?
|
Oral Health | 1 | 2023 | 491 | 0.140 |
Why?
|
Plasma | 1 | 2020 | 586 | 0.140 |
Why?
|
Cross-Sectional Studies | 9 | 2024 | 26071 | 0.140 |
Why?
|
Certification | 2 | 2019 | 418 | 0.130 |
Why?
|
Benzhydryl Compounds | 1 | 2023 | 917 | 0.130 |
Why?
|
Male | 30 | 2024 | 360693 | 0.130 |
Why?
|
Middle Aged | 20 | 2024 | 220853 | 0.130 |
Why?
|
Radioimmunoassay | 1 | 2016 | 862 | 0.130 |
Why?
|
Renal Replacement Therapy | 2 | 2015 | 281 | 0.130 |
Why?
|
Dehydroepiandrosterone | 1 | 2016 | 258 | 0.130 |
Why?
|
Pathology, Clinical | 1 | 2019 | 376 | 0.130 |
Why?
|
Poisson Distribution | 1 | 2016 | 504 | 0.120 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2016 | 125 | 0.120 |
Why?
|
Adult | 18 | 2024 | 221119 | 0.120 |
Why?
|
Psoriasis | 1 | 2023 | 946 | 0.120 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2016 | 550 | 0.110 |
Why?
|
Early Diagnosis | 3 | 2014 | 1186 | 0.110 |
Why?
|
Risk Factors | 11 | 2024 | 74239 | 0.110 |
Why?
|
Bariatric Surgery | 1 | 2024 | 991 | 0.110 |
Why?
|
Female | 26 | 2024 | 392544 | 0.110 |
Why?
|
Pathology | 1 | 2016 | 269 | 0.110 |
Why?
|
Proteinuria | 2 | 2013 | 605 | 0.100 |
Why?
|
Obesity, Morbid | 1 | 2024 | 1277 | 0.100 |
Why?
|
Age Factors | 4 | 2020 | 18384 | 0.100 |
Why?
|
Weight Loss | 1 | 2024 | 2680 | 0.100 |
Why?
|
Bone Diseases, Metabolic | 1 | 2016 | 410 | 0.100 |
Why?
|
Dermatitis, Atopic | 1 | 2019 | 731 | 0.100 |
Why?
|
Logistic Models | 3 | 2020 | 13249 | 0.100 |
Why?
|
Obesity | 2 | 2011 | 12939 | 0.100 |
Why?
|
Kidney Transplantation | 2 | 2011 | 4242 | 0.090 |
Why?
|
Aged | 13 | 2024 | 169288 | 0.090 |
Why?
|
Urethra | 1 | 2012 | 405 | 0.090 |
Why?
|
Cell-Derived Microparticles | 1 | 2012 | 161 | 0.090 |
Why?
|
Heart Failure | 3 | 2024 | 11701 | 0.090 |
Why?
|
CD40 Ligand | 1 | 2012 | 524 | 0.090 |
Why?
|
Albuminuria | 2 | 2024 | 656 | 0.080 |
Why?
|
P-Selectin | 1 | 2012 | 599 | 0.080 |
Why?
|
Quality of Life | 1 | 2011 | 13367 | 0.080 |
Why?
|
Estradiol | 1 | 2016 | 1937 | 0.080 |
Why?
|
Hypertension | 2 | 2023 | 8536 | 0.080 |
Why?
|
Dietary Supplements | 1 | 2011 | 3410 | 0.080 |
Why?
|
Vitamin D | 3 | 2019 | 3301 | 0.080 |
Why?
|
Albumins | 1 | 2011 | 575 | 0.080 |
Why?
|
Nephrectomy | 2 | 2011 | 938 | 0.080 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 8003 | 0.080 |
Why?
|
Interleukin-8 | 1 | 2011 | 696 | 0.080 |
Why?
|
Societies, Medical | 2 | 2019 | 3923 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2020 | 4027 | 0.070 |
Why?
|
Cognition Disorders | 1 | 2011 | 3976 | 0.070 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2014 | 1017 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2022 | 3753 | 0.070 |
Why?
|
Aged, 80 and over | 4 | 2024 | 58952 | 0.070 |
Why?
|
Kidney Tubules | 1 | 2009 | 448 | 0.070 |
Why?
|
Venous Thrombosis | 1 | 2016 | 1304 | 0.070 |
Why?
|
Lithium Carbonate | 1 | 2007 | 179 | 0.070 |
Why?
|
Exercise | 1 | 2023 | 5874 | 0.070 |
Why?
|
Nephritis, Interstitial | 1 | 2007 | 155 | 0.070 |
Why?
|
Testosterone | 1 | 2016 | 2472 | 0.060 |
Why?
|
Sex Factors | 3 | 2019 | 10553 | 0.060 |
Why?
|
Life Style | 1 | 2016 | 3907 | 0.060 |
Why?
|
Comorbidity | 2 | 2016 | 10516 | 0.060 |
Why?
|
Dialysis Solutions | 1 | 2023 | 34 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2374 | 0.060 |
Why?
|
Pulmonary Embolism | 1 | 2016 | 2571 | 0.050 |
Why?
|
Cardiovascular Diseases | 3 | 2024 | 15520 | 0.050 |
Why?
|
Administration, Oral | 2 | 2021 | 4015 | 0.050 |
Why?
|
Vitamin B Deficiency | 1 | 2011 | 12 | 0.050 |
Why?
|
Population Surveillance | 1 | 2012 | 2598 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2016 | 2421 | 0.050 |
Why?
|
Depression | 1 | 2011 | 8132 | 0.050 |
Why?
|
Preoperative Period | 1 | 2024 | 551 | 0.050 |
Why?
|
Prognosis | 3 | 2024 | 29687 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2024 | 15637 | 0.050 |
Why?
|
Urea | 1 | 2023 | 442 | 0.050 |
Why?
|
International Cooperation | 2 | 2019 | 1423 | 0.050 |
Why?
|
Hyperhomocysteinemia | 1 | 2011 | 118 | 0.050 |
Why?
|
Interleukin-6 | 1 | 2011 | 3210 | 0.050 |
Why?
|
Linear Models | 1 | 2011 | 5869 | 0.050 |
Why?
|
Time Factors | 2 | 2021 | 39957 | 0.050 |
Why?
|
Asphyxia | 1 | 2021 | 60 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8663 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2011 | 4340 | 0.040 |
Why?
|
Survival Rate | 1 | 2014 | 12728 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12159 | 0.040 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3821 | 0.040 |
Why?
|
Prospective Studies | 3 | 2016 | 54435 | 0.040 |
Why?
|
Gastrectomy | 1 | 2024 | 671 | 0.040 |
Why?
|
Renin-Angiotensin System | 1 | 2023 | 735 | 0.040 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2024 | 854 | 0.040 |
Why?
|
Glucosides | 1 | 2023 | 512 | 0.040 |
Why?
|
Homocysteine | 1 | 2011 | 637 | 0.040 |
Why?
|
Erythropoiesis | 1 | 2022 | 683 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2022 | 858 | 0.040 |
Why?
|
Boston | 1 | 2011 | 9327 | 0.040 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2023 | 1039 | 0.030 |
Why?
|
Young Adult | 4 | 2016 | 59221 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2023 | 1504 | 0.030 |
Why?
|
Patients | 1 | 2023 | 906 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2011 | 1702 | 0.030 |
Why?
|
Child, Preschool | 5 | 2019 | 42224 | 0.030 |
Why?
|
Education, Distance | 1 | 2019 | 260 | 0.030 |
Why?
|
Gastric Bypass | 1 | 2024 | 818 | 0.030 |
Why?
|
Oliguria | 1 | 2014 | 21 | 0.030 |
Why?
|
Risk Assessment | 2 | 2014 | 24021 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 10218 | 0.030 |
Why?
|
Consanguinity | 1 | 2016 | 457 | 0.030 |
Why?
|
Incidence | 1 | 2012 | 21365 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2011 | 4251 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 8998 | 0.030 |
Why?
|
Iron | 1 | 2022 | 1790 | 0.030 |
Why?
|
Reoperation | 1 | 2024 | 4303 | 0.030 |
Why?
|
Vitamins | 1 | 2011 | 1634 | 0.030 |
Why?
|
Cystostomy | 1 | 2012 | 25 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 1 | 2008 | 3163 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2024 | 80674 | 0.030 |
Why?
|
Laparoscopy | 1 | 2024 | 2035 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2024 | 3813 | 0.020 |
Why?
|
Diuretics | 1 | 2014 | 611 | 0.020 |
Why?
|
Echocardiography | 1 | 2024 | 5006 | 0.020 |
Why?
|
Inflammation | 1 | 2011 | 10759 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2024 | 3899 | 0.020 |
Why?
|
Child | 5 | 2019 | 80152 | 0.020 |
Why?
|
Bipolar Disorder | 1 | 2007 | 5092 | 0.020 |
Why?
|
Stroke Volume | 1 | 2024 | 5521 | 0.020 |
Why?
|
Program Development | 1 | 2016 | 1294 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2016 | 1803 | 0.020 |
Why?
|
Research Design | 1 | 2024 | 6180 | 0.020 |
Why?
|
Sex Distribution | 1 | 2013 | 2277 | 0.020 |
Why?
|
Blood Pressure | 1 | 2023 | 8479 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15841 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6781 | 0.020 |
Why?
|
Age Distribution | 1 | 2013 | 2871 | 0.020 |
Why?
|
Adolescent | 4 | 2019 | 88298 | 0.020 |
Why?
|
Creatinine | 1 | 2012 | 1897 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 15308 | 0.020 |
Why?
|
Kidney Diseases, Cystic | 1 | 2008 | 182 | 0.020 |
Why?
|
Adiposity | 1 | 2016 | 1879 | 0.020 |
Why?
|
Awareness | 1 | 2010 | 649 | 0.020 |
Why?
|
Body Mass Index | 1 | 2024 | 12952 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2024 | 64681 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39126 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3418 | 0.010 |
Why?
|
Chronic Disease | 2 | 2010 | 9319 | 0.010 |
Why?
|
United States | 2 | 2023 | 72339 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 2014 | 2631 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2928 | 0.010 |
Why?
|
Calcium | 1 | 2016 | 5719 | 0.010 |
Why?
|
Curriculum | 1 | 2016 | 3741 | 0.010 |
Why?
|
Infant | 2 | 2014 | 36169 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 22174 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7865 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10707 | 0.010 |
Why?
|
Cohort Studies | 2 | 2014 | 41496 | 0.010 |
Why?
|
Length of Stay | 1 | 2014 | 6417 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2016 | 3406 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2014 | 5295 | 0.010 |
Why?
|
Sepsis | 1 | 2014 | 2585 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2010 | 2317 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2010 | 5250 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2008 | 4822 | 0.010 |
Why?
|
Pilot Projects | 1 | 2010 | 8642 | 0.010 |
Why?
|
Odds Ratio | 1 | 2009 | 9652 | 0.010 |
Why?
|
Massachusetts | 1 | 2009 | 8837 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2010 | 4014 | 0.010 |
Why?
|
Graft Rejection | 1 | 2008 | 4481 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2012 | 26199 | 0.010 |
Why?
|